ATP5O Antibody (N-term) Blocking Peptide
€293.00
In stock
SKU
AC-BP8563a
Background:
ATP5O is a component of the F-type ATPase found in the mitochondrial matrix. F-type ATPases are composed of a catalytic core and a membrane proton channel. This protein appears to be part of the connector linking these two components and may be involved in transmission of conformational changes or proton conductance.
Other Names: ATP synthase subunit O, mitochondrial, Oligomycin sensitivity conferral protein, OSCP, ATP5O, ATPO
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8563a was selected from the N-term region of human ATP5O. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P48047
Gene ID: 539
Gene Name: ATP5PO (HGNC:850)
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Wang,L., et.al., Cancer Epidemiol. Biomarkers Prev. 17 (12), 3558-3566 (2008)Contessi,S., et.al., J. Bioenerg. Biomembr. 39 (4), 291-300 (2007)
ATP5O is a component of the F-type ATPase found in the mitochondrial matrix. F-type ATPases are composed of a catalytic core and a membrane proton channel. This protein appears to be part of the connector linking these two components and may be involved in transmission of conformational changes or proton conductance.
Other Names: ATP synthase subunit O, mitochondrial, Oligomycin sensitivity conferral protein, OSCP, ATP5O, ATPO
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8563a was selected from the N-term region of human ATP5O. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P48047
Gene ID: 539
Gene Name: ATP5PO (HGNC:850)
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Wang,L., et.al., Cancer Epidemiol. Biomarkers Prev. 17 (12), 3558-3566 (2008)Contessi,S., et.al., J. Bioenerg. Biomembr. 39 (4), 291-300 (2007)
| Is Featured? | No |
|---|
Write Your Own Review